-
公开(公告)号:WO2021259815A1
公开(公告)日:2021-12-30
申请号:PCT/EP2021/066725
申请日:2021-06-21
发明人: BELL, Andrew Simon , BESNARD, Jérémy , BRADLEY, Anthony Richard , GREEN, Luke , HAAP, Wolfgang , KOCER, Buelent , KUGLSTATTER, Andreas , LUCAS, Xavier , MATTEI, Patrizio , MAZUNIN, Dmitry , RATNI, Hasane , RIEMER, Claus , VAN HOORN, Willem Paul
IPC分类号: C07D239/95 , C07D401/12 , C07D403/06 , C07D403/12 , C07D417/04 , C07D471/04 , C07D473/04 , A61P35/00 , A61K31/00
摘要: The present invention provides compounds of formula I or II: wherein X1, X3, R1, R2, R3, R4 and R5 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula I, pharmaceutical compositions comprising them and their use as medicaments.
-
公开(公告)号:WO2022162034A1
公开(公告)日:2022-08-04
申请号:PCT/EP2022/051823
申请日:2022-01-27
发明人: BELL, Andrew Simon , BESNARD, Jérémy , BRADLEY, Anthony Richard , GREEN, Luke , HAAP, Wolfgang , KOCER, Buelent , KUGLSTATTER, Andreas , LUCAS, Xavier , MATTEI, Patrizio , MAZUNIN, Dmitry , RIEMER, Claus , VAN HOORN, Willem Paul
IPC分类号: C07D471/04 , C07D487/04 , A61K31/437 , A61P35/00
摘要: The present invention provides compounds of formula I or II: (I) wherein X1, R1 and R2 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula I, pharmaceutical compositions comprising them and their use as medicaments.
-
公开(公告)号:WO2021259831A1
公开(公告)日:2021-12-30
申请号:PCT/EP2021/066767
申请日:2021-06-21
发明人: BELL, Andrew, Simon , BESNARD, Jérémy , BRADLEY, Anthony, Richard , GREEN, Luke , HAAP, Wolfgang , KOCER, Buelent , KUGLSTATTER, Andreas , LUCAS, Xavier , MATTEI, Patrizio , MAZUNIN, Dmitry , RIEMER, Claus , VAN HOORN, Willem Paul
IPC分类号: C07D231/56 , C07D487/04 , A61P35/00 , A61K31/416
摘要: The present invention provides compounds of formula (I) wherein X1, X2, X3, X4, R1, R1a, R1b, R2', R2", R3', R3", R6 and R7 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.
-
-